NO20031743D0 - Krystallinsk venlafaksinbase og nye venlafaksinhydrokloridpolymorfer og fremgangsmåter for fremstilling av dette - Google Patents

Krystallinsk venlafaksinbase og nye venlafaksinhydrokloridpolymorfer og fremgangsmåter for fremstilling av dette

Info

Publication number
NO20031743D0
NO20031743D0 NO20031743A NO20031743A NO20031743D0 NO 20031743 D0 NO20031743 D0 NO 20031743D0 NO 20031743 A NO20031743 A NO 20031743A NO 20031743 A NO20031743 A NO 20031743A NO 20031743 D0 NO20031743 D0 NO 20031743D0
Authority
NO
Norway
Prior art keywords
venlafaxine
novel
processes
preparation
crystalline
Prior art date
Application number
NO20031743A
Other languages
English (en)
Other versions
NO20031743L (no
Inventor
Ben-Zion Dolitzky
Judith Aronhime
Shlomit Wizel
Gennady Nisnevish
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27500045&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20031743(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of NO20031743D0 publication Critical patent/NO20031743D0/no
Publication of NO20031743L publication Critical patent/NO20031743L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/10—Separation; Purification; Stabilisation; Use of additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20031743A 2000-10-19 2003-04-15 Krystallinsk venlafaxinbase og nye polyformer av venlafaxin- hydroklorid, samt fremgangsmåte for fremstilling derav NO20031743L (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US24157700P 2000-10-19 2000-10-19
US25886100P 2000-12-29 2000-12-29
US27872101P 2001-03-26 2001-03-26
US29246901P 2001-05-21 2001-05-21
PCT/US2001/051017 WO2002045658A2 (en) 2000-10-19 2001-10-19 Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof

Publications (2)

Publication Number Publication Date
NO20031743D0 true NO20031743D0 (no) 2003-04-15
NO20031743L NO20031743L (no) 2003-06-18

Family

ID=27500045

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031743A NO20031743L (no) 2000-10-19 2003-04-15 Krystallinsk venlafaxinbase og nye polyformer av venlafaxin- hydroklorid, samt fremgangsmåte for fremstilling derav

Country Status (20)

Country Link
US (1) US20020143211A1 (no)
EP (1) EP1334082A4 (no)
JP (2) JP2004530638A (no)
KR (1) KR20030059206A (no)
CN (1) CN1620420A (no)
AU (1) AU2002241764A1 (no)
CA (1) CA2426158A1 (no)
CZ (1) CZ20031298A3 (no)
DE (1) DE01988460T1 (no)
ES (1) ES2206082T1 (no)
HR (1) HRP20030392A2 (no)
HU (1) HUP0303496A3 (no)
IL (2) IL155400A0 (no)
IS (1) IS6789A (no)
MX (1) MXPA03003459A (no)
NO (1) NO20031743L (no)
PL (1) PL365895A1 (no)
SK (1) SK5762003A3 (no)
WO (1) WO2002045658A2 (no)
YU (1) YU30203A (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020183553A1 (en) * 2000-10-19 2002-12-05 Ben-Zion Dolitzky Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
EP1330427A1 (en) * 2000-10-31 2003-07-30 Ciba SC Holding AG Crystalline forms of venlafaxine hydrochloride
HUP0104872A3 (en) * 2001-11-13 2004-04-28 Egis Gyogyszergyar Nyilvanosan New polymorphic forms of venlafaxine, process for their preparation, pharmaceutical compositions containing them and their use
EP1451145A1 (en) * 2001-12-05 2004-09-01 Wyeth Novel crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof
UA77234C2 (en) * 2001-12-05 2006-11-15 Wyeth Corp Monohydrate of venlafaxine hydrochloride and methods for its preparation (variants)
WO2003050074A1 (en) * 2001-12-13 2003-06-19 Cadila Healthcare Limited Manufacture of venlafaxine hydrochloride and crystalline polymorphs thereof
US6696496B2 (en) 2002-03-28 2004-02-24 Synthon Bv Low water-soluble venlafaxine salts
EP1485344A1 (en) 2002-03-28 2004-12-15 Synthon B.V. Venlafaxine besylate
AU2003226752A1 (en) * 2002-03-28 2003-10-13 Synthon B.V. Venlafaxine base
DE10359154A1 (de) * 2003-12-16 2005-07-28 Krka Tovarna Zdravil, D.D. Verfahren zur Herstellung von Venlafaxin und Venlafaxinhydrochlorid der Form I
US7468428B2 (en) 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
WO2006043577A1 (ja) * 2004-10-20 2006-04-27 Mitsubishi Pharma Corporation フェニルエタノールアミン化合物の製造方法及びその中間体
JP2009511641A (ja) * 2005-10-19 2009-03-19 テバ ファーマシューティカル インダストリーズ リミティド 高純度１−〔２−ジメチルアミノ−（４−メトキシフェニル）エチル〕シクロヘキサノール塩酸塩の調製方法
WO2007049302A2 (en) * 2005-10-28 2007-05-03 Ind-Swift Laboratories Limited An improved process for the preparation of pure venlafaxine
WO2008000418A2 (en) 2006-06-27 2008-01-03 Sandoz Ag New method for salt preparation
EP2081885A2 (en) * 2006-07-14 2009-07-29 Medichem, S.A. Improved processes for preparing venlafaxine base and salts thereof
DK2621891T3 (da) * 2010-10-01 2020-02-17 Shan Dong Luye Pharm Co Ltd Polymorfer af 4-[2-dimethylamino-1-(1 hydroxycyclohexyl)ethyl]phenyl 4-methylbenzoathydrochlorid, fremgangsmåder til fremstilling og anvendelse deraf
TWI665190B (zh) 2013-11-15 2019-07-11 阿克比治療有限公司 ｛［５－（３－氯苯基）－３－羥基吡啶－２－羰基］胺基｝乙酸之固體型式，其組合物及用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4535186A (en) * 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
US4611078A (en) * 1983-10-26 1986-09-09 American Home Products Corporation Substituted phenylacetonitriles
AR255595A1 (no) 1994-07-13 2002-05-24 Gador Sa
PE57198A1 (es) * 1996-03-25 1998-10-10 American Home Prod Formula de liberacion prolongada
US6197828B1 (en) * 1998-12-01 2001-03-06 Sepracor, Inc. Derivatives of (+)-venlafaxine and methods of preparing and using the same
US20020183553A1 (en) * 2000-10-19 2002-12-05 Ben-Zion Dolitzky Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
EP1330427A1 (en) 2000-10-31 2003-07-30 Ciba SC Holding AG Crystalline forms of venlafaxine hydrochloride
AU2001235970A1 (en) 2000-12-07 2002-06-18 Dr. Reddy's Research Foundation Novel crystalline polymorphic forms of venlafaxine hydrochloride and a process for their preparation

Also Published As

Publication number Publication date
EP1334082A2 (en) 2003-08-13
IS6789A (is) 2003-04-15
IL155400A0 (en) 2003-11-23
NO20031743L (no) 2003-06-18
US20020143211A1 (en) 2002-10-03
ES2206082T1 (es) 2004-05-16
HRP20030392A2 (en) 2005-04-30
PL365895A1 (en) 2005-01-10
CZ20031298A3 (cs) 2003-10-15
AU2002241764A1 (en) 2002-06-18
CA2426158A1 (en) 2002-06-13
WO2002045658A3 (en) 2003-01-16
YU30203A (sh) 2006-08-17
WO2002045658A2 (en) 2002-06-13
HUP0303496A3 (en) 2005-08-29
CN1620420A (zh) 2005-05-25
EP1334082A4 (en) 2006-02-01
MXPA03003459A (es) 2005-04-29
IL196287A0 (en) 2011-08-01
KR20030059206A (ko) 2003-07-07
DE01988460T1 (de) 2004-04-22
SK5762003A3 (en) 2003-11-04
JP2008239629A (ja) 2008-10-09
HUP0303496A2 (hu) 2004-01-28
JP2004530638A (ja) 2004-10-07

Similar Documents

Publication Publication Date Title
NO20031743D0 (no) Krystallinsk venlafaksinbase og nye venlafaksinhydrokloridpolymorfer og fremgangsmåter for fremstilling av dette
NO20040680L (no) Nye dihydropterinonerfremgangsmate for fremstilling derav og deres anvendelse som legemiddel
DK1227088T3 (da) Krystallinsk base af citalopram og hydrochlorid- eller hydrobromidsaltet deraf
ATE454138T1 (de) Tablette mit modifizierter freisetzung von bupropion hydrochlorid
NO20040266L (no) Nye krystallinske polymorfe former av lerkanidipinhydroklorid og fremgangsmate for fremstilling derav
DK1487840T3 (da) Krystallinsk polymorf form af irinotecan hydrochlorid
DK1147075T3 (da) Fremgangsmåde til fremstilling af L-phenylephrinhydrochlorid
AU1234002A (en) Crystalline forms of venlafaxine hydrochloride
NO20042732L (no) Krystallinsk venlafaksin-base og nye polymorfe former av venlafaksin-hydroklorid samt fremgangsmater for fremstilling derav
HRP20030900A2 (en) Polymorphs of fexofenadine hydrochloride
IL162255A0 (en) Novel crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof
NO20015058L (no) Nye ribose-substituerte aromatiske amider, fremgangsmåte for deres fremstilling og deres anvendelse som legemidler
NO20042810L (no) Venflaxine-hydroklorid-monohydrat og fremgangsmater for fremstilling derav
NO20030822L (no) Nye forbindelser og fremgangsmåter
AU2001235970A1 (en) Novel crystalline polymorphic forms of venlafaxine hydrochloride and a process for their preparation
AU2002247945A1 (en) Manufacture of venlafaxine hydrochloride and crystalline polymorphs thereof
NO20040479L (no) Solvater av lerkanidipinhydroklorid og nye krystallinske former av lerkanidipinhydroklorid.
NO20014077D0 (no) Fremgangsmate for a krystallisere N-(4-trifluormetylfenyl)-5- metyl-isoksazol-4-karboksamid
PL372137A1 (en) A novel polymorph of sertraline hydrochloride and composition containing thereof, novel methods for preparation of sertraline hydrochloride polymorphs and amorphous form
PL376832A1 (pl) Sposób wytwarzania polimorficznej postaci chlorowodorku sertraliny

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application